Advertisement
Advertisement

RVTY

RVTY logo

Revvity, Inc.

86.15
USD
Sponsored
-0.47
-0.54%
May 01, 12:02 UTC -4
Open

RVTY Earnings Reports

Positive Surprise Ratio

RVTY beat 30 of 40 last estimates.

75%

Next Report

Next Week
Date of Next Report
May 05, 2026
Estimate for Q1 26 (Revenue/ EPS)
$717.37M
/
$1.03
Implied change from Q4 25 (Revenue/ EPS)
-7.08%
/
-39.41%
Implied change from Q1 25 (Revenue/ EPS)
+7.91%
/
+1.98%

Revvity, Inc. earnings per share and revenue

On Feb 02, 2026, RVTY reported earnings of 1.70 USD per share (EPS) for Q4 25, beating the estimate of 1.58 USD, resulting in a 7.45% surprise. Revenue reached 772.06 million, compared to an expected 776.51 million, with a -0.57% difference. The market reacted with a -1.57% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 17 analysts forecast an EPS of 1.03 USD, with revenue projected to reach 717.37 million USD, implying an decrease of -39.41% EPS, and decrease of -7.08% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
BrightSpring Health Services, Inc. Common Stock
Report Date
May 01, 2026 For Q1 26
Estimate
$0.31
Actual
$0.39
Surprise
+23.34%
logo
Bausch + Lomb Corporation
Report Date
Apr 29, 2026 For Q1 26
Estimate
$0.05
Actual
$0.08
Surprise
+36.52%
logo
Avantor, Inc.
Report Date
Apr 29, 2026 For Q1 26
Estimate
$0.16
Actual
$0.17
Surprise
+6.18%
logo
Alignment Healthcare, Inc. Common Stock
Report Date
Apr 30, 2026 For Q1 26
Estimate
$0.00
Actual
$0.05
Surprise
+575.68%
logo
HCA Healthcare, Inc.
Report Date
Apr 24, 2026 For Q1 26
Estimate
$7.21
Actual
$7.15
Surprise
-0.85%
logo
Elevance Health, Inc.
Report Date
Apr 22, 2026 For Q1 26
Estimate
$10.93
Actual
$12.58
Surprise
+15.10%
logo
Labcorp Holdings Inc.
Report Date
Apr 30, 2026 For Q1 26
Estimate
$4.21
Actual
$4.25
Surprise
+0.80%
logo
Medpace Holdings, Inc. Common Stock
Report Date
Apr 22, 2026 For Q1 26
Estimate
$3.95
Actual
$4.28
Surprise
+8.14%
logo
Teladoc Health, Inc.
Report Date
Apr 29, 2026 For Q1 26
Estimate
-$0.31
Actual
-$0.36
Surprise
-12.64%
logo
CareDx, Inc.
Report Date
Apr 28, 2026 For Q1 26
Estimate
$0.13
Actual
$0.34
Surprise
+149.63%
FAQ
For Q4 2025, Revvity, Inc. reported EPS of $1.70, beating estimates by 7.45%, and revenue of $772.06M, -0.57% below expectations.
The stock price moved down -1.57%, changed from $108.80 before the earnings release to $107.09 the day after.
The next earning report is scheduled for May 05, 2026.
Based on 17 analysts, Revvity, Inc. is expected to report EPS of $1.03 and revenue of $717.37M for Q1 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement